CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- PositionPrice-to-book is 0.65×, lower than 95% of its Medical Devices peers (median 2.69×)
- FinancialsLow earnings quality
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.92BCNY582.81M · vs all stocks (USD)
Revenue (TTM)
1.01BCNY150.45M · vs all stocks (USD)
Profit Margin
-54.56%vs Medical Devices peers
Beta
0.8280xvs all stocks
52-Week Change
-34.75%vs all stocks
Market Capitalization
3.92BCNY582.81M · vs all stocks (USD)
Enterprise Value
1.65BCNY244.96M · vs all stocks (USD)
Forward P/E
0.7474xvs Medical Devices peers
Price to Sales (TTM)
4.00xvs Medical Devices peers
Price to Book (MRQ)
0.6514xvs Medical Devices peers
Enterprise to Revenue
1.63xvs Medical Devices peers
Enterprise to EBITDA
-6.98xvs Medical Devices peers
Gross Margin
42.89%vs Medical Devices peers
Profit Margin
-54.56%vs Medical Devices peers
Operating Margin
-29.01%vs Medical Devices peers
Return on Assets (TTM)
-3.52%vs Medical Devices peers
Return on Equity (TTM)
-9.10%vs Medical Devices peers
Revenue (TTM)
1.01BCNY150.45M · vs all stocks (USD)
Revenue per Share (TTM)
5.33CNYUpdated Aug 21, 2026Quarterly Revenue Growth
33.50%vs Medical Devices peers
Gross Profit (TTM)
418.16MCNY62.18M · vs all stocks (USD)
EBITDA (TTM)
-235.85MCNY-35.07M · vs all stocks (USD)
Net Income (TTM)
-551.99MCNY-82.09M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
50.48%vs Medical Devices peers
Operating Cash Flow (TTM)
-168.72MCNY-25.09M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-451.74MCNY-67.18M · vs all stocks (USD)
Payout Ratio
0.00%vs Medical Devices peers
Minority Interest (Equity)
92.96MCNYFY2025 · Dec 31, 2025Revenue
947.38MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
560.90MCNYFY2025 · Dec 31, 2025Gross Profit
386.48MCNYFY2025 · Dec 31, 2025Operating Income
-446.89MCNY-66.46M · vs all stocks (USD)
Pre-tax Income
-583.49MCNYFY2025 · Dec 31, 2025Income Tax Expense
13.91MCNYFY2025 · Dec 31, 2025Net Income
-597.41MCNYFY2025 · Dec 31, 2025EBIT
-573.58MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
-170.78MCNYFY2025 · Dec 31, 2025Research & Development
230.81MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
227.67MCNYFY2025 · Dec 31, 2025Other Operating Expenses
19.87MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
80.35MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
9.91MCNYFY2025 · Dec 31, 2025EPS (Basic)
-2.98CNYFY2025 · Dec 31, 2025EPS (Diluted)
-2.98CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
192.48MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
192.48MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-597.41MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
23.81MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-644.51MCNYFY2025 · Dec 31, 2025Free Cash Flow
-949.56MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.64BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-597.41MCNYFY2025 · Dec 31, 2025Other Non-cash Items
38.57MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-71.21MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-14.47MCNYFY2025 · Dec 31, 2025Capital Expenditures
-305.05MCNYFY2025 · Dec 31, 2025Purchase of Investments
-416.55MCNYFY2025 · Dec 31, 2025Sale of Investments
475.37MCNYFY2025 · Dec 31, 2025Other Investing Activity
823.83MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
577.60MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
384.00MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-510.06MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-6.71MCNYFY2025 · Dec 31, 2025Other Financing Charges
-66.70MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-199.48MCNYFY2025 · Dec 31, 2025Shares Outstanding
201.60MSharesUpdated Aug 21, 2026Float Shares
93.50MSharesUpdated Aug 21, 2026% Held by Insiders
51.39%vs all stocks
% Held by Institutions
2.02%vs all stocks
Total Cash (MRQ)
2.40BCNY356.98M · vs all stocks (USD)
Total Cash per Share (MRQ)
12.54CNYUpdated Aug 21, 2026Total Debt (MRQ)
326.11MCNY48.50M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0545xvs Medical Devices peers
Current Ratio (MRQ)
3.79xvs Medical Devices peers
Book Value per Share (MRQ)
30.80CNYUpdated Aug 21, 2026Total Assets
7.14BCNY1.06B · vs all stocks (USD)
Total Current Assets
3.26BCNYFY2025 · Dec 31, 2025Total Liabilities
1.05BCNYFY2025 · Dec 31, 2025Total Non-current Assets
3.88BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
221.41MCNYFY2025 · Dec 31, 2025Total Current Liabilities
831.86MCNYFY2025 · Dec 31, 2025Cash
1.64BCNYFY2025 · Dec 31, 2025Cash Equivalents
810.56MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
2.45BCNYFY2025 · Dec 31, 2025Other Short-term Investments
122.59MCNYFY2025 · Dec 31, 2025Accounts Receivable
213.06MCNYFY2025 · Dec 31, 2025Inventory
309.86MCNYFY2025 · Dec 31, 2025Accounts Payable
481.40MCNYFY2025 · Dec 31, 2025Short-term Debt
141.67MCNYFY2025 · Dec 31, 2025Other Current Liabilities
1.44MCNYFY2025 · Dec 31, 2025Long-term Debt
184.29MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
5.94MCNYFY2025 · Dec 31, 2025Common Stock (Book)
201.60MCNYFY2025 · Dec 31, 2025Retained Earnings
5.61BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
6.09BCNY905.00M · vs all stocks (USD)
Treasury Stock
326.94MCNYFY2025 · Dec 31, 202552-Week Low
17.03CNYUpdated Aug 21, 202652-Week High
30.00CNYUpdated Aug 21, 202652-Week Change
-34.75%vs all stocks
Beta
0.8280xvs all stocks
50-Day MA
19.10CNYUpdated Aug 21, 2026200-Day MA
22.68CNYUpdated Aug 21, 2026Avg 10-Day Volume
1.86MSharesUpdated Aug 21, 2026Avg 30-Day Volume
1.69MSharesUpdated Aug 21, 2026Diluted EPS (TTM)
-2.90CNYUpdated Aug 21, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Diagnostic
Declining With Price Stretched Below 1Y Mean
The price sits well below its yearly mean, with net income and assets falling four years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Price-to-book is 0.65×, lower than 95% of its Medical Devices peers (median 2.69×)Notable
Price-to-book: 0.65Industry median: 2.69Industry P5: 0.66Peers compared: 102
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.43Profit Margin: -0.55
Financial Health
Low earnings qualitySignificant
Earnings Quality Score: -0.52
Altman Z-Score 3.61: safe zoneNotable
Altman Z-Score: 3.61
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Zhuhai Rundu Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
ChemoCentryx Inc
Tier 1ProductionApproval-Gated PipelineRule
Nanjing Hicin Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
4D Molecular Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Ningbo David Medical Device Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
FDC Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Zhejiang Starry Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Zeria Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai Xiao Feng Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Hunan Hansen Pharmaceutical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Wuhan Easydiagnosis Biomedicine Co., Ltd.
1 interpretationDeclining With Price Stretched Below 1Y Mean
Longfor Group Holdings Limited
1 interpretationDeclining With Price Stretched Below 1Y Mean
Qatari Investors Group
1 interpretationDeclining With Price Stretched Below 1Y Mean